Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs PHARMACEUTICAL GATEKEEPERS Nearly One-Third Of New Drugs Are No Better Than Older Drugs, And Some Are Worse The FDA Breakthrough-Drug Designation — Four Years of Experience Luxturna: FDA documents reveal the value of a costly gene therapy A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis